Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CMRX:US

39.4800 USD 0.5300 1.32%

As of 20:10:00 ET on 04/24/2015.

Snapshot for Chimerix Inc (CMRX)

Open: 40.0100 Day's Range: 39.4300 - 40.5300 Volume: 215,214
Previous Close: 40.0100 52wk Range: 14.0200 - 43.4100 1-Yr Rtn: +110.00%

Stock Chart for CMRX

No chart data available.
  • CMRX:US 39.4800
  • 1D
  • 1M
  • 1Y
40.0100
Interactive CMRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CMRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.7700
Est. EPS (USD) (12/2015) -2.5190
Est. PEG Ratio -
Market Cap (M USD) 1,622.08
Shares Outstanding (M) 41.09
30 Day Average Volume 392,546
Price/Book (mrq) 5.8985
Price/Sale (ttm) 322.8982
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CMRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CMRX

Chimerix, Inc. is a biopharmaceutical discoverers and commercializes oral antiviral therapeutics. The Company develops novel antiviral therapeutics with the potential to transform patient care in multiple settings including transplant, oncology, acute care, and global health. Chimerix operates in the United States.

M Michelle BerreyPresident/CEOWilliam Garrett NicholsChief Medical Officer
Linda M RichardsonChief Commercial OfficerMichael D RogersChief Development Officer
More Company Profile & Key Executives for CMRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil